SCHEMBL25501426

SCHEMBL25501426

c1ccc2cc(-c3nc(-c4ccc5ccc6oc7ccccc7c6c5c4)nc(-c4cccc5oc6ccccc6c45)n3)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PIM1 P11309 1/20 0.37
ALDH1A1 P00352 5/20 0.36
MAPT P10636 4/20 0.36
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 1/20 0.36
CYP1A2 P05177 3/20 0.36
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
CYP2C19 P33261 2/20 0.36
CASP3 P42574 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
CYP2C9 P11712 1/20 0.36
KDM4E B2RXH2 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ESR1 P03372 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25847252 0.99 CASP3 (0.38) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25502923 0.96 CASP3 (0.36) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25502903 0.96 CASP3 (0.36) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25501436 0.96 CASP3 (0.36) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25502570 0.95 HCRTR1 (0.38) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25503027 0.95 TDP1 (0.35) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25502645 0.95 HCRTR1 (0.38) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25501758 0.95 PIM1 (0.38) TDP1L3MBTL1PIM1ALDH1A1MAPT
SCHEMBL25501241 0.95 TDP1 (0.38) TDP1L3MBTL1ALDH1A1MAPTCYP1A1
SCHEMBL23822237 0.94 CASP3 (0.38) TDP1L3MBTL1PIM1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023132694-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-07-13 WO disclosed
WO-2023096318-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 주식회사 엘지화학 2023-06-01 WO disclosed
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2023-05-18 US disclosed
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230157156-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, VDAC2, ICOSLG TDP1 643/4885L3MBTL1 1328/4885PIM1 2078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.